MSFT
44
3
PSX
40
-2
PG
48
-5
ALL
50
-3
EMR
67
-3
AVY
47
-3
INTC
43
-2
AVGO
33
2
O
50
-7
VIX
43
8
TSCO
44
-2
NWS
44
-2
AA
69
-3
CMCSA
39
7
BAX
41
-3
CNP
55
-2
AN
61
-2
CCL
58
3
CTAS
28
-8
BRK.B
40
-3
MSFT
44
3
PSX
40
-2
PG
48
-5
ALL
50
-3
EMR
67
-3
AVY
47
-3
INTC
43
-2
AVGO
33
2
O
50
-7
VIX
43
8
TSCO
44
-2
NWS
44
-2
AA
69
-3
CMCSA
39
7
BAX
41
-3
CNP
55
-2
AN
61
-2
CCL
58
3
CTAS
28
-8
BRK.B
40
-3
Financhill
Back

Alaunos Therapeutics, Inc. 10K Form

Buy
64

TCRT
Alaunos Therapeutics, Inc.

Last Price:
$4.05
Seasonality Move:
10.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCRT News And Ratings

See the #1 stock for the next 7 days that we like better than TCRT

TCRT Financial Statistics

Sales & Book Value

Annual Sales: $10K
Cash Flow: $-941K
Price / Cash Flow: 0
Annual Sales: $1.27
Price / Book: 3.26

Profitability

EPS (TTM): -2.31070
Net Income (TTM): $-4M
Gross Margin: $8K
Return on Equity: -163.5%
Return on Assets: -119.2%

Alaunos Therapeutics, Inc. Earnings Forecast

Key Alaunos Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 21 years for TCRT is 80.00%.
  • The Selling, General & Administrative Expenses for TCRT have been equal to 44,600.00% of Gross Profit Margin.
  • The Research & Development expenses have been 3,620.00% of Revenue.
  • The Net Earning history of TCRT is -46,790.00% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 15 years.

Alaunos Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TCRT
Website: alaunos.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.92
Quick Ratio: 2.1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TCRT Technical Analysis vs Fundamental Analysis

Buy
64
Alaunos Therapeutics, Inc. (TCRT) is a Buy

Is Alaunos Therapeutics, Inc. a Buy or a Sell?